November 29, 2012
Six UCSF researchers have been selected this year as fellows of the American Association for the Advancement of Science (AAAS) for scientific work or socially distinguished efforts to advance science and its applications.
November 16, 2012
Health warning labels have adorned cigarette packages since 1966, when they first appeared in the United States. And in the decades since, they have spread steadily around the world – in many instances, becoming more strongly worded, more prominently placed and more graphic over time.
November 14, 2012
Personalized medicine advances arising from genetic discoveries were the primary focus of wide-ranging presentations at the UCSF Institute for Human Genetics 2012 Symposium on Nov. 5.
November 8, 2012
A 20-year study following 110,645 workers who helped clean up after the 1986 Chernobyl nuclear power plant accident in the former Soviet territory of Ukraine shows that the workers share a significant increased risk of developing leukemia.
November 1, 2012
One of the toughest issues facing patients who have surgery for very early-stage lung cancer is uncertainty: Despite complete removal of their small lung tumors and no evidence of metastasis, at least one quarter of patients harbor tiny, undetectable clumps of cancer cells that have already spread outside their lungs and will kill them within a few years.
October 15, 2012
Three UCSF faculty members are among the 70 newly elected members of the Institute of Medicine (IOM), which recognizes those who have demonstrated outstanding professional achievement and commitment to service in the areas of medical sciences, health care and public health.
October 12, 2012
UCSF is one of six medical schools that will receive a total of $5.2 million in grant funding from the Doris Duke Charitable Foundation (DDCF) to offer clinical research fellowships in global health over the next four years.
October 10, 2012
For the first time since 1997, UCSF is embarking on a new long-range development plan. The goal is to guide the University’s physical development through the year 2035, to support its long-term goals of providing excellence in patient care, innovative science and health sciences education.
October 10, 2012
A Phase I clinical trial led by investigators from the University of California, San Francisco (UCSF) and sponsored by Stem Cells Inc., showed that neural stem cells successfully engrafted into the brains of patients and appear to have produced myelin.
October 9, 2012
Many men survive prostate cancer, but thousands of others — whose cancer spreads — inevitably develop resistance to even the most promising treatments, leaving them with few medical options and a dwindling span of life.
Excellent research enhances therapies for brain cancer.
Meet more of Our Heroes »
Copyright © 2013-2014 University of California Regents. All Rights Reserved.
UCSF Helen Diller Family Comprehensive Cancer Center
Site Map | Terms of Use & Privacy Policy | Contact Webmaster
Subscribe to RSS
